You just read:

Launches of First Therapies Approved for Spinal Muscular Atrophy and Friedreich's Ataxia Will Revolutionize Treatment and Drive Growth of These Rare Disease Markets

News provided by

Decision Resources Group

Oct 25, 2016, 08:32 ET